Literature DB >> 28672776

Human U3 protein 14a plays an anti-apoptotic role in cancer cells.

Teng Ma1, Chenxi Lu1, Yafei Guo1, Chunfeng Zhang1, Xiaojuan Du1.   

Abstract

Human U three protein 14a (hUTP14a) binds p53 and promotes p53 degradation. Here, we report that hUTP14a plays an anti-apoptotic role in tumor cells through a p53-independent pathway. Knockdown of hUTP14a activated the intrinsic pathway of apoptosis and sensitized tumor cells to chemotherapeutic drug-induced apoptosis. In addition, the protein level of hUTP14a decreased upon chemotherapeutic drug- or irradiation-induced apoptosis. Importantly, the decrease of hUTP14a during induced apoptosis was not blocked by pan-caspase inhibitor z-VAD-FMK, indicating that the down-regulation of hUTP14a is an upstream event in apoptosis. Furthermore, ectopically expressed hUTP14a protected tumor cells from chemotherapeutic drug-induced apoptosis. In summary, our data showed that hUTP14a protected tumor cells from chemotherapeutic drug-induced apoptosis and thus might possess a potential as a target for anti-tumor therapy.

Entities:  

Keywords:  apoptosis; hUTP14a; intrinsic pathway of apoptosis; p53-independent

Mesh:

Substances:

Year:  2017        PMID: 28672776     DOI: 10.1515/hsz-2017-0121

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  3 in total

1.  [Expression of hUTP14a in non-small cell lung cancer].

Authors:  C F Zhang; Y Liu; M Lu; X J DU
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-02-18

Review 2.  Ubiquitination of Nonhistone Proteins in Cancer Development and Treatment.

Authors:  Xiuzhen Zhang; Tong Meng; Shuaishuai Cui; Ling Feng; Dongwu Liu; Qiuxiang Pang; Ping Wang
Journal:  Front Oncol       Date:  2021-02-11       Impact factor: 6.244

3.  Overexpression of U three protein 14a (UTP14a) is associated with poor prognosis of esophageal squamous cell carcinoma.

Authors:  Kun-Kun Li; Cheng-Yi Mao; Jing-Ge Zhang; Qiang Ma; Ying-Jian Wang; Xue-Hai Liu; Tao Bao; Wei Guo
Journal:  Thorac Cancer       Date:  2019-09-08       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.